Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials.

Detalles Bibliográficos
Publicado en:	Drug Safety Vol. 49; no. 6; pp. 667 - 676
Autores principales:	Chimonas, Susan, Cosenza, Carol, Kesselheim, Aaron S., Toyserkani, Gita A., Oswell, Kate Heinrich, LaCivita, Cynthia, Dal Pan, Gerald J., Sarpatwari, Ameet
Formato:	Journal Article
Publicado:	Springer Nature Jun2026
Acceso en línea:	Ver este registro en EBSCOhost